Introduction 1
factor induce the production of serum amyloid A (SAA) from the various tissues. In the same way, different inflammatory conditions such as infection, trauma or presence of malignancy may cause the rise of SAA which is most likely derived from the liver cells (Kisilevsky et al., 2012) . Elevated level of SAA was found to be allied with the various forms of cancers with shortened survival. Though the extensive study has not been done to see the association between SAA concentration and renal cell carcinoma, some findings suggest that evaluation of SAA level in patients with RCC may be a useful prognostic indicator (Fischer et al., 2012) . To the best of our knowledge, association of SAA and renal cell carcinoma has not been reported in Nepalese population so for. Thus the main objective of our undertaken study was to assess the role of SAA in prognosis of renal cell carcinoma and to show an association between the level of SAA and stages of renal cell carcinoma.
Materials and Methods
It was a hospital based retrospective study carried out in the Department of Medicine and Biochemistry of Manipal Teaching Hospital, Pokhara, Nepal between 1 st January 2008 and 31 st December 2011. The variables collected were SAA, CRP. Approval for the study was obtained from the institutional research ethical committee. Quantitative Analysis of Human serum amyloid A protein (SAA) and C-reactive protein (CRP) was performed by radial immune diffusion (RID) assay for all cases (Chambers et al., 1983 
Results
Of the 422 total cases of renal cell carcinoma, 218 patients had normal SAA and 204 patients had abnormal SAA. Table 1 illustrates that number of patients were divided according to their classification of renal cell carcinoma and CRP levels with normal and elevated SAA levels. The maximum number of patients having normal SAA belongs to T2 stage (36) of RCC. The maximum number of patients having elevated SAA belongs to M0 stage (32) of RCC. 59 patients were having normal serum CRP and SAA. Further, 35 patients of RCC were having elevated serum CRP and SAA. Table 2 depicts that there was significant difference in between normal and elevated SAA levels in pathological classification and with respect to CRP levels. The maximum mean value in normal SAA levels was observed in M0 stage (5.6±SD1.2) of RCC. The maximum mean value in elevated SAA levels was observed in other subtypes (203.9±SD20.9) of pathological classification.
The mean values of SAA were noticeably raised in elevated CRP levels (209.1±SD22.7) and was statistically significant (p value: 0.0001). Table 3 shows that SAA levels were grossly elevated in T3 stage (122.3 ± SD35.7) when compared to the mean values of SAA in T2 stage (84.2 ± SD24.4) and were statistically significant (p value: 0.0001). Similarly, SAA levels were grossly elevated in M1 stage (190.0 ± SD12.7) when compared to the mean values of SAA in M0 stage (160.9±SD24.8) and was statistically significant (p value: 
Discussion
Numerous promising markers for renal cell cancer have been acknowledged; presently not any biomarkers have been authenticated and are in routine use (Eichelberg et al., 2009 ). This study demonstrated the utility of SAA as potential prognostic serum biomarker. In our current study, prognostic significance was evaluated by TNM staging system that includes tumour grade and histological subtype. There was noteworthy disparity between the values of normal SAA and abnormal SAA for all pathological factors and CRP levels; p Value (Wood et al., 2010) . In contrast to that, the groups compared for Grade classification confirm the mild difference in levels of SAA in G2 (200.00±20.17) as compared to G1 (192.13±12.56); p Value (0.199) . Likewise, in our present study, results indicate that there was insignificant difference for groups equated for cell classification; p Value (0.383). SAA has been documented as acute-phase reactant whose level in the blood is elevated to 1000-fold as part of the body's responses to various injuries, including trauma, infection, inflammation, and neoplasia. Functions of SAA describing to tumourigenesis (Malle et al., 2009 ) by attaching to extracellular matrix components with consequent potential modification of cell binding, augmentation of plasminogen activation and triggering of matrix metalloproteinase (MMP) production, and was accounted in numerous cell forms including renal cancer cell lines (Paret et al., 2010) . Another inflammatory acute phase protein is CRP. It is also increased in tumour, infections and inflammation (Johnson et al., 2012) . Serum C-reactive protein has been reported as a prognostic biomarkers in localized and metastatic renal cell carcinoma (Johnson et al., 2011) . SAA values were mildly raised in elevated CRP (209.15± 22.79) when compared to normal CRP levels (199.00±19.50) and it was statistically insignificant; p Value (0.177). These findings warrant further study in larger patient groups to determine conclusively the prognostic value of SAA and CRP in combination.
In conclusion, validity of SAA in serum as an independent prognostic significance in RCC was demonstrated with higher levels in advanced stage disease.
